227 related articles for article (PubMed ID: 36454803)
21. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F
J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878
[TBL] [Abstract][Full Text] [Related]
22. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
[TBL] [Abstract][Full Text] [Related]
23. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.
Burger M; Shariat SF; Fritsche HM; Martinez-Salamanca JI; Matsumoto K; Chromecki TF; Ficarra V; Kassouf W; Seitz C; Pycha A; Tritschler S; Walton TJ; Novara G
World J Urol; 2011 Aug; 29(4):465-72. PubMed ID: 21630120
[TBL] [Abstract][Full Text] [Related]
24. Impact of lymph node dissection on clinical outcomes during nephroureterectomy in patients with clinically node-negative upper urinary tract urothelial cancer: subanalysis of a multi-institutional nationwide case series of the Japanese Urological Association.
Inokuchi J; Eto M; Hara T; Fujimoto H; Nishiyama H; Miyazaki J; Kikuchi E; Hinotsu S; Koie T; Ohyama C;
Jpn J Clin Oncol; 2017 Jul; 47(7):652-659. PubMed ID: 28398494
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
[TBL] [Abstract][Full Text] [Related]
26. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
27. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Chen JC; Huang TH; Wei TC; Huang IS; Fan YH; Lin CC; Lin TP; Chung HJ; Lu SH; Kuo JY; Wu HHH; Chang YH; Lin ATL; Huang WJ; Huang EY
World J Urol; 2023 Dec; 41(12):3575-3583. PubMed ID: 37924334
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for overall survival in clinical node-positive patients with upper tract urothelial carcinoma.
Sasahara T; Yanagisawa T; Sugaya S; Hisakane A; Sakanaka K; Hara S; Otsuka T; Takamizawa S; Yata Y; Takahashi Y; Takiguchi Y; Mori K; Tsuzuki S; Kimura S; Miki J; Kimura T
Int J Urol; 2024 Apr; 31(4):386-393. PubMed ID: 38169105
[TBL] [Abstract][Full Text] [Related]
30. Benefit of lymph node dissection in cN+ patients in the treatment of upper tract urothelial carcinoma: Analysis of NCDB registry.
Piontkowski AJ; Corsi N; Morisetty S; Majdalany S; Rakic I; Li P; Arora S; Jamil M; Rogers C; Autorino R; Abdollah F
Urol Oncol; 2022 Sep; 40(9):409.e9-409.e17. PubMed ID: 35623996
[TBL] [Abstract][Full Text] [Related]
31. Benefits of lymphadenectomy for upper tract urothelial carcinoma only located in the lower ureter: a bicentre retrospective cohort study.
Cui Y; Lu Y; Wu J; Quan C
Front Oncol; 2023; 13():1115830. PubMed ID: 37124512
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.
Winer AG; Vertosick EA; Ghanaat M; Corradi RB; Carlsson S; Sjoberg DD; Sankin AI; Sfakianos JP; Cha EK; Dalbagni G; Coleman JA
Urol Oncol; 2017 Apr; 35(4):151.e9-151.e15. PubMed ID: 27932270
[TBL] [Abstract][Full Text] [Related]
33. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
[TBL] [Abstract][Full Text] [Related]
34. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
[TBL] [Abstract][Full Text] [Related]
35. The long-term outcome of nephron-sparing surgery versus radical nephroureterectomy for organ-localized upper urinary tract urothelial carcinoma: a population-based study of 1969 patients.
Qiu J; Deng R; Yu C; Gong K
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14869-14878. PubMed ID: 37598342
[TBL] [Abstract][Full Text] [Related]
36. Role of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma.
Lenis AT; Donin NM; Faiena I; Salmasi A; Johnson DC; Drakaki A; Gollapudi K; Blumberg J; Belldegrun A; Pantuck A; Chamie K
Urol Oncol; 2018 Jan; 36(1):9.e1-9.e9. PubMed ID: 29066013
[TBL] [Abstract][Full Text] [Related]
37. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
38. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
[TBL] [Abstract][Full Text] [Related]
39. Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis.
Cirulli GO; Corsi N; Rakic I; Stephens A; Chiarelli G; Finati M; Davis M; Tinsley S; Sood A; Buffi N; Lughezzani G; Carrieri G; Salonia A; Briganti A; Montorsi F; Rogers C; Abdollah F
BJU Int; 2024 May; 133(5):555-563. PubMed ID: 38097533
[TBL] [Abstract][Full Text] [Related]
40. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
